Sinovac found to have 83.5% efficacy in Turkey China Daily | Updated: 2021-03-05 09:47 Serhat Unal (right) and Murat Akova of Ankara s Hacettepe University announce the findings of phase III trials of Sinovac s COVID-19 vaccine on Wednesday. RASIT AYDOGAN/GETTY IMAGES
ISTANBUL－A COVID-19 vaccine made by Chinese drugmaker Sinovac Biotech has an efficacy of 83.5 percent based on phase III trials in Turkey, a Turkish university said on Wednesday.
The results were based on 10,216 participants aged 18-59, 3,568 of whom had received a placebo as part of the trials that began in mid-September, said Serhat Unal, a medical faculty member of the Department of Infectious Diseases and Clinical Microbiology at Ankara s Hacettepe University, and a member of Turkey s Coronavirus Scientific Advisory Board.
Sinovac found to have 83 5% efficacy in Turkey
chinadaily.com.cn - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from chinadaily.com.cn Daily Mail and Mail on Sunday newspapers.
Guyana receives donated COVID-19 vaccines from China - World News
sina.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sina.com Daily Mail and Mail on Sunday newspapers.
Guyana receives donated COVID-19 vaccines from China
chinadaily.com.cn - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from chinadaily.com.cn Daily Mail and Mail on Sunday newspapers.
US encourages Guyana to build Taiwanese ties
FORGING RELATIONS: More countries should deepen their unofficial ties with Taiwan, the AIT said, adding that US support for the nation is ‘rock solid’
By Lin Chia-nan / Staff reporter
The US encourages Guyana and Taiwan to advance their partnership and more countries to expand “unofficial ties” with Taiwan, the American Institute in Taiwan (AIT) said in a statement yesterday.
The statement came after Guyana reneged on an agreement made with Taiwan on Jan. 11 to establish a Taiwan office in the South American country, citing its adherence to the “one China” policy and “miscommunication” over the signed agreement.